97 related articles for article (PubMed ID: 11563078)
1. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106)1: antitumor effect and mechanism of action.
Azuma A; Matsuda A; Sasaki T; Fukushima M
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):609-19. PubMed ID: 11563078
[TBL] [Abstract][Full Text] [Related]
2. Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity.
Hattori H; Tanaka M; Fukushima M; Sasaki T; Matsuda A
J Med Chem; 1996 Dec; 39(25):5005-11. PubMed ID: 8960561
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of a new antitumor ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), differs from that of 5-fluorouracil.
Kazuno H; Shimamoto Y; Tsujimoto H; Fukushima M; Matsuda A; Sasaki T
Oncol Rep; 2007 Jun; 17(6):1453-60. PubMed ID: 17487404
[TBL] [Abstract][Full Text] [Related]
4. Antitumor mechanisms and metabolism of the novel antitumor nucleoside analogues, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil.
Takatori S; Kanda H; Takenaka K; Wataya Y; Matsuda A; Fukushima M; Shimamoto Y; Tanaka M; Sasaki T
Cancer Chemother Pharmacol; 1999; 44(2):97-104. PubMed ID: 10412942
[TBL] [Abstract][Full Text] [Related]
5. 1-(3-C-Ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), a novel potent inhibitor of RNA polymerase, potentiates the cytotoxicity of CDDP in human cancer cells both in vitro and in vivo.
Kazuno H; Fujioka A; Fukushima M; Wataya Y; Matsuda A; Sasaki T
Int J Oncol; 2009 May; 34(5):1373-80. PubMed ID: 19360349
[TBL] [Abstract][Full Text] [Related]
6. PK-PD modeling of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and the enhanced antitumor effect of its phospholipid derivatives in long-circulating liposomes.
Takada A; Kamiya H; Shuto S; Matsuda A; Harashima H
Int J Pharm; 2009 Jul; 377(1-2):52-9. PubMed ID: 19426792
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor effect and mechanism of a novel multifunctional nucleoside, 3'-ethynylnucleoside, on human cancers].
Tanaka M; Tabata S; Matsuda A; Fukushima M; Eshima K; Sasaki T
Gan To Kagaku Ryoho; 1997 Feb; 24(4):476-82. PubMed ID: 9063487
[TBL] [Abstract][Full Text] [Related]
8. Anticancer mechanisms of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl) cytosine (ECyd, TAS-106).
Naito T; Yokogawa T; Kim HS; Futagami M; Wataya Y; Matsuda A; Fukushima M; Kitade Y; Sasaki T
Nucleic Acids Res Suppl; 2002; (2):241-2. PubMed ID: 12903195
[TBL] [Abstract][Full Text] [Related]
9. A new antitumor nucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd), is a potent inhibitor of RNA synthesis.
Matsuda A; Fukushima M; Wataya Y; Sasaki T
Nucleosides Nucleotides; 1999; 18(4-5):811-4. PubMed ID: 10432683
[TBL] [Abstract][Full Text] [Related]
10. Nucleosides and nucleotides. 175. Structural requirements of the sugar moiety for the antitumor activities of new nucleoside antimetabolites, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and -uracil1.
Hattori H; Nozawa E; Iino T; Yoshimura Y; Shuto S; Shimamoto Y; Nomura M; Fukushima M; Tanaka M; Sasaki T; Matsuda A
J Med Chem; 1998 Jul; 41(15):2892-902. PubMed ID: 9667977
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic mechanisms of new antitumor nucleoside analogues, 3'-ethynylcytidine (ECyd) and 3'-ethynyluridine (EUrd).
Kanda H; Takatori S; Matsuda A; Sasaki T; Tanaka M; Fukushima M; Wataya Y
Nucleic Acids Symp Ser; 1997; (37):137-8. PubMed ID: 9586037
[TBL] [Abstract][Full Text] [Related]
12. Possible antitumor activity of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106) against an established gemcitabine (dFdCyd)-resistant human pancreatic cancer cell line.
Kazuno H; Sakamoto K; Fujioka A; Fukushima M; Matsuda A; Sasaki T
Cancer Sci; 2005 May; 96(5):295-302. PubMed ID: 15904471
[TBL] [Abstract][Full Text] [Related]
13. An RNA-directed nucleoside anti-metabolite, 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl)cytosine (ECyd), elicits antitumor effect via TP53-induced Glycolysis and Apoptosis Regulator (TIGAR) downregulation.
Lui VW; Lau CP; Cheung CS; Ho K; Ng MH; Cheng SH; Hong B; Tsao SW; Tsang CM; Lei KI; Yamasaki Y; Mita A; Chan AT
Biochem Pharmacol; 2010 Jun; 79(12):1772-80. PubMed ID: 20219441
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic mechanisms of inhibitor of RNA synthesis, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106).
Yokogawa T; Takenaka K; Ogawa D; Futagami M; Matsuda A; Fukushima M; Kitade Y; Wataya Y
Nucleic Acids Symp Ser; 2000; (44):193-4. PubMed ID: 12903334
[TBL] [Abstract][Full Text] [Related]
15. Role of RNase L in apoptosis induced by 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine.
Naito T; Yokogawa T; Takatori S; Goda K; Hiramoto A; Sato A; Kitade Y; Sasaki T; Matsuda A; Fukushima M; Wataya Y; Kim HS
Cancer Chemother Pharmacol; 2009 Apr; 63(5):837-50. PubMed ID: 18668243
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity and pharmacokinetics of TAS-106, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine.
Shimamoto Y; Fujioka A; Kazuno H; Murakami Y; Ohshimo H; Kato T; Matsuda A; Sasaki T; Fukushima M
Jpn J Cancer Res; 2001 Mar; 92(3):343-51. PubMed ID: 11267946
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of the cyclic and acyclic acetal derivatives of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine, a potent antitumor nucleoside. Design of prodrugs to be selectively activated in tumor tissues via the bio-reduction-hydrolysis mechanism.
Nomura M; Shuto S; Matsuda A
Bioorg Med Chem; 2003 May; 11(11):2453-61. PubMed ID: 12735992
[TBL] [Abstract][Full Text] [Related]
18. A crucial role of uridine/cytidine kinase 2 in antitumor activity of 3'-ethynyl nucleosides.
Murata D; Endo Y; Obata T; Sakamoto K; Syouji Y; Kadohira M; Matsuda A; Sasaki T
Drug Metab Dispos; 2004 Oct; 32(10):1178-82. PubMed ID: 15280220
[TBL] [Abstract][Full Text] [Related]
19. Anticancer molecular mechanism of 3'-ethynylcytidine (ECyd).
Wataya Y; Futagami M; Naito T; Uchikubo Y; Yokogawa T; Takenaka K; Kim HS; Matsuda A; Fukushima M; Kitade Y
Nucleic Acids Res Suppl; 2001; (1):233-4. PubMed ID: 12836350
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic mechanism of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd).
Wataya Y; Takenaka K; Yokogawa T; Matsuda A; Sasaki T; Fukushima M
Nucleic Acids Symp Ser; 1999; (42):133-4. PubMed ID: 10780415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
